Indiana University-Purdue University Indianapolis (IUPUI) / Craniofacial growth results from both environmental and genetic factors over time. It would be exciting to isolate genetic factors that influence treatment responses from patients undergoing orthodontic treatment. Genetic genotyping and analysis of orthodontic patients is a new technologic advancement. The aim of this retrospective study is to examine the relationship of a specific single nucleotide polymorphism (SNP), rs6180, of the Growth Hormone Receptor (GHR) gene with various craniofacial length parameters in patients who have received Herbst appliance therapy as part of orthodontic treatment. An initial lateral cephalometric radiograph was taken along with two buccal cheek swabs. The cells obtained have undergone DNA isolation with the Puregene method in microcentrifuge tubes (Gentra Systems, Minneapolis, MN). Upon termination of functional appliance therapy (post-Herbst), a final lateral cephalometric radiograph was taken. To analyze the genetic polymorphism and determine genotype, polymerase chain reaction (PCR) and allelic discrimination were done using the 7000 Sequence Detection System (Applied Biosystems). Lateral cephalometric radiographs (initial, post-Herbst) of 25 patients were digitized and measured using the Dolphin Imaging program. Cephalometric measurements (S-N, S-A, Co-Go, Go-Gn, Ar-Gn, Go-Gn) were used to identify mandibular and craniofacial morphologic changes. Changes in Z-scores based on standards from the Michigan Growth Study were then converted to slow or normal growth status by slow being when the Z-score difference between the initial and final measurements is less than zero. The number of subjects with a slow versus normal growth status was compared to GHR polymorphism genotype. Statistical analysis of Hardy-Weinberg equilibrium and the changes in craniofacial length Z-scores in relation to a patient's genotype were performed using chi-square analysis. Results: The genotype frequencies were in Hardy-Weinberg equilibrium. Z-score differences for the S-A measurement was the only one found to be significant (p=0.005).

No description available.

Thesis (MScAgric)--University of Stellenbosch, 2005. / ENGLISH ABSTRACT: Porcine somatotropin (pST) is a naturally occurring protein (hormone), secreted by the pituitary gland of young pigs and is one of the major growth regulating factors. High levels of pST is found in circulating blood of young animals, resulting in the partitioning of nutrients into lean tissue and bone growth. Supplying an exogenous source of pST should increase the deposition of lean muscle and bone and decrease the deposition of fat in the older (above 60 kg) pig. To ascertain whether pST would have a positive influence on production- and meat characteristics in the South African scenario for pigs slaughtered at a high bodymass, a trail was conducted. For group housed animals pST had no significant effect on the following parameters: feed intake, calculated cumulatively on a weekly basis, ADG, live weight, carcass weight, carcass length, ham length or chest depth, intramuscular fat area, muscle depth and colour measured with a Hennessey probe and waterbinding capacity. However, when the FCR of pigs in this investigation were calculated, there was a significant (p<0.05) influence by sex and pST detected. Boars converted their feed to live weight better than barrows and gilts from week ten onwards. Boars had an increased FCR when treated with pST. A significant increase was found in muscle area and a significant decrease in extra muscular (back fat) area of boars and barrows. A significant pST (p< 0.05) effect (3 mm reduction) was seen for backfat depth measured by the Hennessey probe and the intrascope. Porcine somatotropin significantly (p<0.05) increased the muscle area of the loin-cut for all animals. The area covered by subcutaneous fat of boars and barrows were significantly (P<0.05) reduced by pST treatment, with no effect detected for gilts (p>0.05). Porcine somatotropin treatment increased the muscle percentage and decreased the extramuscular fat percentage in such a way that the differences between sexes was reduced. Thus, more uniform fat-muscle distribution between carcasses was obtained by pST treatment. Control animals had a significantly higher pH24 than pST treated animals (P=0.049). Lower values were found for animals receiving pST for L* (p=0.016), a* (p=0.002) and b* (P=0.016). The effect on b* (yellow-blue range) in the M longissimus thoracis of pST treated animals showed slightly (but significantly) less yellow and more green compared to control animals (p=0.016). This combined with the lower L* values (brightness) indicates that pST treated animals had a significantly darker colour meat compared to the control animals. Individually housed animals showed no significant differences for the following characteristics: live weight, carcass weight, head, trotters, shoulder, middle back, middle belly, loin belly, thigh, fillet, carcass fat and kidney. Whereas pST caused a significantly lower percentage of the middle back of boars and barrows, but not in gilts, pST could only precipitate a lower percentage (11.18%) loin back of treated animals (p=0.026) v.s. control animals (12.05%). A trend (p>0.1) was detected for percentage bone in the middle back, with the pST treated (14.17% vs. 13.18%) animals having more bone than that of control animals. pST animals had a higher percentage (p=0.024) skin (5.04%) than the control animals (4.28%). This study shows that there is no negative effect of pST on meat quality characteristics and carcass composition, in fact there is less variation between carcasses obtained from different sexes treated with pST. The producer can bring heavier animals to the market with a reduced backfat percentage and a greater percentage meat with the help of pST. / AFRIKAANSE OPSOMMING: Vark somatotropien (pST) is ‘n natuurlike hormoon wat deur die pituitêre klier in die brein afgeskei word by klein varkies en is een van die belangrikste hormone betrokke by groei regulering. Hoë vlakke van pST kom voor in die bloed van jong varkies, dit veroorsaak dan die verspreiding van nutriente in die liggaam van die varkie sodat dit meer vleis en beengroei toon en minder vet deponeer. Namate die varkie volwasse word neem die bloedvlakke van pST af en begin die liggam meer vet deponeer ten koste van proteien groei, terselfde tyd begin die seksuele kenmerke ontwikkel. Die toediening van ‘n eksterne bron van pST behoort die groei van been en vleis te bevoordeel in ouer diere (bo 60 kg). Vir die doeleindes van die ondersoek wou ons bepaal of pST ‘n positewe effek het op groei en vleiskwaliteitseienskappe van varke wat in Suid Afrikaanse kondisies gebruik word en teen ’n hoër liggamsmassa as gewoonlik geslag word. Vir varke wat in groepe behuis was was daar geen effek op die volgende eienskappe nie: voer inname weekliks bepaa, gemiddelde daaglikse toename, liggaamsmassa, karkasgewig, karkas lengte, ham lengte, bors diepte, intrmuskulêre vet en spierdikte bepaal met ‘n Hennessey sonde asook waterbindigs vermoë. Bere het egter ’n beter voeromsettings faktor gehat as burge en soggies, maar as pST toegedien is het hulle voeromsettingsfaktor toegeneem. ’n Betekenisvolle (p<0.05) toename in spier area van alle diere, met ’n gesamentlike afname in onderhuidse vet area van bere en burge (nie soggies nie) is gevind. ’n Betekenisvolle afname (3 mm) in rugvetdikte is gevind by diere wat met pST behandel is. Hierdie effekte is so in die lewe gebring dat die verskil tussen die geslagte minder prominent is en karkasse meer uniform is. Betekenisvolle hoër pH24 waardes is gevind by kontrole diere as by pST behandelde diere (p=0.049). L* (p=0.016), a* (p=0.002) en b* (p=0.016) waardes was betekenisvol laer vir pST behandelde diere as vir kontrole diere. Die effek op b* waardes (geel-blou reeks) in die M. longissimus thoracis van behandelde diere was in so ‘n mate dat die vleis ietwat minder geel en meer groen was in vergelyking met die kontrole diere (p=0.016), saam met laer L* waardes (helderheid) is ‘n indikasie van ietwat donkerder vleis van behandelde diere. Individueel behuisde diere het geen betekenisvolle effek getoon vir die volgende parameters nie: liggamsgewig, karkasgewig, kop, voete, skouer, middel rug, middel maag, lende maag, dy, haas en niere. ‘n Betekenisvolle laer persentasie middel rug is gevind in bere en burge, maar nie vir soggies nie, maar in die lende rug is ‘n betekenisvolle effek gevind vir alle diere (11.8% vir pST en 12.05% vir kontroe , p=0.026). ‘n Neiging (p>0,1) is gesien vir die hoeveelheid been in die middle rug van diere behandel met pST (14.17% vs. 13.18%) Dier met pSt behandel het’n betekenisvol hoer persentasie vel as kontrole diere gehat (5.04% vs. 4.28%, p=0.024. Die resultate van die ondersoek bewys dat daar geen negatiewe effekte van pST op vleis- en karkaseienskappe is nie, daar is self minder variasie tussen karkasse van verskillende geslagte. Die boer kan swaarder diere bemark met minder rugvet en meer vleis met behulp van pST.

O presente trabalho teve por objetivo verificar o efeito de diferentes níveis de IGF-I no colostro de vacas que receberam rbST durante o período pré-parto, no desenvolvimento do trato intestinal e na expressão do gene do IGF-I e de seu receptor no fígado e intestino de bezerros. Quarenta e duas vacas da raça Holandesa, gestantes e multíparas foram distribuídas ao acaso em dois grupos de 21 animais, o grupo rbST que recebeu hormônio de crescimento (500 mg rbST) e o grupo controle que recebeu injeção de vitamina E. As aplicações tiveram início aos 35 dias pré-parto, em intervalos de 14 dias até a data de parição. Os bezerros recém-nascidos foram distribuídos aleatoriamente, de acordo com as seguintes idades em que foram abatidos: após o nascimento e sem a ingestão de colostro, dois e sete dias de vida com ingestão de colostro das respectivas mães. Após o abate, amostras do fígado e segmentos do intestino delgado (jejuno e íleo) foram coletadas para quantificação de DNA, RNA, proteína total e o RNAm do IGF-I e do receptor tipo I. O delineamento experimental utilizado foi o inteiramente casualizado, numa estrutura fatorial 2x3, correspondendo aos grupos das mães (rbST ou controle) e as idades dos bezerros (após o nascimento, dois e sete dias de vida). No fígado, as concentrações de RNA e proteína (mg/g tecido) foram maiores no segundo dia de vida e a relação proteína/RNA aumentou no sétimo dia de vida (P<0,05). O jejuno apresentou interações entre os tratamentos nas concentrações de DNA, proteína e relações proteína/RNA e RNA/DNA (P<0,05). Os bezerros que consumiram colostro proveniente de vacas que receberam rbST apresentaram, no jejuno, maiores concentrações de DNA no segundo dia de vida e diminuição a níveis intermediários entre nascimento e dois dias, comparados aos sete dias de vida. Este efeito também foi observado na relação proteína/RNA. No grupo controle, também se verificou aumento de DNA aos dois dias, mas não houve diferenças aos sete dias, e a relação proteína/RNA foi semelhante entre as idades. A concentração de proteína no jejuno do grupo rbST aumentou no segundo dia de vida e diminuiu no sétimo, enquanto que no grupo controle, este aumento foi verificado apenas no sétimo dia de vida. A relação RNA/DNA diminuiu apenas no grupo controle (P<0,05). A expressão do gene do IGF-I foi maior ao nascimento e aos sete dias de idade no fígado dos bezerros do grupo rbST (P<0,05). As concentrações do gene do receptor tipo I diminuíram com a idade dos bezerros (P<0,05). Ao nascimento, o intestino dos bezerros apresentou condição de resposta celular à presença do IGF-I proveniente do colostro. Os resultados sugerem que as células do jejuno de bezerros do grupo rbST apresentaram um diferente estágio de maturação. / The objective of this study was to verify the effect of different levels of IGF-I in colostrum of cows treated with rbST during dry period, in the development of the intestinal tract and IGF-I and receptor gene expression in the liver and intestine of calves. Forty-two Holstein cows, in gestation and multiparous, were randomly assigned in two groups of 21 animals. Group rbST received injection of growth hormone (rbST), and group control received vitamin E injection. Both treatments started 35 days pre-partum, and were administered every 14 days until parturition. Newborn calves were randomly assigned to the following ages of slaughter: just after birth and without colostrum ingestion; two and seven days of life with colostrum ingestion from their respective mothers. After slaughter, samples from liver and small intestine (jejunum and ileum) were collected for quantification of DNA, RNA, total protein and mRNA of IGF-I and receptor type I. A completely randomized design was used with 2X3 factorial arrangements of treatments, which the factors were the mother’s group (control and rbST) and age (just after birth, two and seven days of life). In the liver, RNA and protein concentrations (mg/g tissue) were higher in the second day of age and protein/RNA ratio increased in the seventh day (P<0.05). The jejunum showed interaction among the treatments in the concentrations of DNA and protein, and protein/RNA RNA/DNA ratios (P<0.05). Calves fed colostrum from mothers that received rbST presented, in jejunum, higher DNA concentration in the second day of life, and decrease to intermediate levels between birth and two days, compared to seven days of age. This effect was also observed in protein/RNA ratio. In the control group, it was also verified DNA increase at two days, but there was not difference in the seventh day, and protein/RNA ratio was similar among ages. Protein concentration in jejunum of rbST group increased in the second day and decreased in the seventh, but in the control group, this increase was verified only in the seventh day of age. RNA/DNA ratio decreased in the control group (P<0.05). Expression of IGF-I was higher at birth and seven days old in the liver of the calves from rbST group (P<0.05). The concentrations of receptor type I mRNA decreased with calves’ age (P<0.05). At birth, the small intestine of calves showed a condition of cellular response to the presence of IGF-I in colostrum. These results suggest that cells in jejunum of calves from rbST group presented a different phase of maturation.

O objetivo do presente trabalho foi estudar a influência do uso da somatotropina bovina (bST) sobre a produção de leite e a avaliação genética de bovinos da raça Holandesa. Para análise foram utilizados dados referentes a 474 touros e observações referentes a 3341 lactações de 1271 vacas, provenientes da Agropecuária Agrindus - S.A no estado de São Paulo no período de 1999 a 2003. Análise de variância (método dos quadrados mínimos) foi realizada pelo procedimento GLM do SAS® (2003), visando identificar o efeito da classe de aplicação do bST sobre a produção de leite aos 305 dias de lactação (PL305). Os valores genéticos preditos dos touros (PBV), componentes de variância e herdabilidade para a característica PL305 foram estimados utilizando-se um modelo animal a partir de duas análises; na primeira incluiu-se o efeito do bST como fixo e na segunda o referido efeito foi ignorado. Foram calculadas correlações de Spearman entre PBV dos touros para quatro conjuntos de touros avaliados: a) todos os touros; b) os melhores 20%; c) os melhores 10% e d) os melhores 5%. As médias da PL305 para as classes de bST foram 9175,11kg - sem bST, 9530,94kg - de 11 a 20 aplicações, 10150,57kg - de 21 a 30 aplicações e 11089,89 Kg de 31 a 59 aplicações. As herdabilidades foram respectivamente de 0,26±0,00 e 0,23±0,00 para as duas análises e as correlações entre os valores genéticos preditos para os conjuntos de touros a, b, c e d foram, respectivamente, 0,9484, 0,9829, 0,9752 e 0,8974. A análise de variância demonstrou as médias de PL305 aumentaram significativamente (P<0,0001), com o aumento do número de aplicações do bST. Os coeficientes de herdabilidade, embora relativamente baixos, indicam possível ganho genético, por meio de seleção, para produção de leite. As altas correlações de Spearman entre os valores genéticos dos touros, considerando-se ou não o uso do bST no modelo, indicam que o uso desta tecnologia não interfere na classificação dos touros avaliados geneticamente. / The aim of this study was to investigate the influence of the use of the bovine somatotropin (bST) on the milk production and the bovine genetic evaluation of Holstein cattle. Data regarding 474 bulls and observation concerning 3341 lactations of 1271 cows from the Agrindus Agriculture and Cattle Raising S.A. in the state of São Paulo, Brazil, between 1999 and 2003 were used for the analysis. The variance analysis (the minimum square method) was performed by the GLM procedure of the SAS® (2003) for identify the effects of the application class of the bST on the milk production at 305 days of lactation (PL305). For the bulls, the predicted breeding values (PBV), variance components and heritability for the PL305 characteristic were estimated using an animal model from two analyses; in the first, the bST was considered as fixed effect and in the second, the effect of bST was ignored. Spearman correlations between PBV for four sets of evaluated bulls were calculated: a) all bulls; b) the best 20%; c) the best 10% and d) the best 5%. The PL305 averages for the bST classes were 9175.11kg without bST; 9530.94kg from 11 to 20 applications; 10150.57kg from 21 to 30 applications; and 11089.89kg from 31 to 59 applications. The heritabilities were 0.26±0.00 and 0.23±0.00 respectively for both analyses and the correlations between the PBV for a, b, c, and d bull sets were, respectively, 0.9484, 0.9829, 0.9752 and 0.8974. The variance analysis demonstrated that the PL305 averages increased significantly (P<0.0001) with the increase of number of bST applications. The heritability coefficients, although relatively low, indicate a possible genetic gain, by selection, for milk production. The Spearman high correlations between the PBV of bulls, considering or not the bST use in the model, indicate that the use of this technology does not interfere in the genetically evaluated bulls classification.

Dentre os diversos fatores que provocam diminuição no desempenho reprodutivo, a degeneração testicular térmica é o motivo mais freqüente de baixa fertilidade em Bos taurus no Brasil. Baseados nos efeitos sobre a secreção de hormônios hipofisários e gonadais, o GH vem sendo estudado para o tratamento da infertilidade masculina. Um delineamento experimental tipo blocos ao acaso utilizou dezesseis touros adultos submetidos a 4 tratamentos em esquema fatorial 2x2 (0 e 96 horas de insulação testicular, 0 e 1,2 mg bST/kg PV), com o objetivo de testar os efeitos da bST no tratamento de touros submetidos a insulação testicular. Motilidade, alterações de acrossoma, defeitos de cauda e cabeça, gota protoplasmática proximal e defeitos espermáticos totais aumentaram em conseqüência da insulação testicular. As concentrações seminais de Testosterona foram temporariamente diminuídas em resposta a insulação testicular. A ocorrência de gota protoplasmática distal, anomalias de peça intermediária e concentrações seminais de IGF1 não foram afetadas pela insulação testicular. A somatotropina recombinante bovina não afetou as características espermáticas ou concentrações seminais de Testosterona e IGF1. / Testicular heat degeneration is the most common cause of poor fertility of Bos taurus bulls in the tropics. The Growth Hormone has been studied in man infertility treatment with some progress. A randomly blocks experimental design used 16 mature bulls allotted in 4 treatments in a 2x2 factorial arrangement (0 e 96 hours of scrotal insulation, 0 e 1,2 mg bST/kg BW) was performed to asses the effects ob bulls submitted to scrotal insulation. Motility, abnormal acrosome, tail and head defects, proximal droplet, and abnormal sperm increased, and seminal plasma Testosterone was temporally increased in response to scrotal insulation. Distal droplet, midpiece and seminal plasma IGF1 were not affected by bST. The bST did not affect sperm characteristics or seminal Testosterone and IGF1.

Bioinformatic searching on the zebrafish genome indicates that there are five members of this hormone family (namely GH, SLalpha, SLbeta, PRL1 and PRL2) and four receptors (namely GHR1, GHR2, PRLR1 and PRLR2). However, it should be noted that these ligands and receptors are only named according to their sequence homology with those in other species. There is so far no systematic study to unravel the relationship among the ligands and receptors. The last point is particularly relevant as some of the ligands and receptors are duplicated in the fish genome. In addition, there is much controversy regarding whether one of the two GHRs is in fact the receptor for SL. A systematic study on the interaction among the ligands and receptors in zebrafish would help to resolve these issues. / In fish, growth hormone (GH), prolactin (PRL) and somatolactin (SL) are members of a gene family of polypeptide hormones which share homology in protein sequence and structure. To date, numerous functions have been attributed to this family of hormones such as growth, immune response, protein metabolism and ion regulation. The biological functions of GHlPRL are mediated through binding of the ligands on their respective receptors. It is believed that this gene family arose as the result of multiple gene duplications and subsequent divergent evolution, co-evolving with their corresponding receptors. Despite the above mentioned similarities in their structures, their cognate receptors and their signaling mechanisms, important differences among this gene family of polypeptide hormones can be recognized in their biological functions. / In the present study, the luciferase reporter assay, His-tag pulldown assay and signaling pathway activation were employed to investigate the interaction among the ligands and their receptors. It was shown that recombinant zebrafish GH, PRLI and PRL2 could only interact with their cognate receptors, i.e. GHRl, GHR2, PRLRI and PRLR2 respectively. In comparison, zebrafish SLalpha and SLbeta could neither interact with GHR1, GHR2, PRLR1 and PRLR2 in the binding study, nor could these two SLs activate the receptor-mediated downstream signaling and transcriptional activities of the four receptors in zebrafish. These data argue against the hypothesis that GHRI is the SL receptor. / The role of PRLR in early development of zebrafish was also explored. Whole mount in situ hybridization (WISH) study showed that PRLR1 was mainly expressed in the pancreas and pronephric duct, while PRLR2 was expressed in the pronephric duct only. In the PRLR1 morpholino (MO) knockdown embryos, the yolk extension (YE), the formation of which was reported to be associated with pronephric duct development, disappeared at 24 hours post fertilization. This phenotype could not be observed in the PRLR2 MO knockdown or control embryos. Real time quantitative RT-PCR and WISH data revealed that several genes expressed in the pronephric duct were up or down-regulated. The protein expression pattern of pronephric duct marker atplal was also affected in the embryos injected with PRLRI MO. In addition, histological studies showed that structure of the pronephric duct was destroyed in the PRLRI MO embryos. These results suggest that PRLRI plays an important role in the development of the pronephric duct in zebrafish embryos. / Chen, Mingliang. / "October 2010." / Adviser: Cheung Wing-Tai. / Source: Dissertation Abstracts International, Volume: 73-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 140-179). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Submitted by Angela Maria de Oliveira (amolivei@uepg.br) on 2017-11-24T13:23:07Z No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Lidiane Pescke Pereira.pdf: 897636 bytes, checksum: 92549067a59b73ac61dbce09ee1c1ee0 (MD5) / Made available in DSpace on 2017-11-24T13:23:07Z (GMT). No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Lidiane Pescke Pereira.pdf: 897636 bytes, checksum: 92549067a59b73ac61dbce09ee1c1ee0 (MD5) Previous issue date: 2017-09-20 / Com o aumento da produtividade e da demanda nutricional pela fêmea suína, o uso de moduladores L-carnitina, L-arginina, cromo, somatotropina e ractopamina tem sido uma alternativa para melhorar os índices produtivos. Entretanto, a variabilidade nas informações e a complexidade dos estudos envolvendo o tema exige uma abordagem mais sistêmica. Objetivou-se por meio desta meta-análise determinar o efeito do uso de moduladores nutricionais no desempenho reprodutivo e das leitegadas de porcas em gestação e lactação. A base de dados utilizada incluiu 83 artigos publicados entre os anos de 1989 e 2017, totalizando 22.608 porcas em 534 tratamentos. Critérios foram estabelecidos para a seleção dos artigos: uso de moduladores nutricionais: L-carnitina, L-arginina, cromo, somatotropina e ractopamina; conter as variáveis corporais e reprodutivas de porcas gestantes e lactantes. A meta-análise envolveu as análises de heterogeneidade, gráfica, correlação, variância e de resíduos. Não houve correlação (P>0,05) entre o uso de moduladores nutricionais e as variáveis corporais das porcas. No estudo de correlações verificou-se que a suplementação com L-carnitina, L-arginina e cromo aumentam (>0,450; P<0,05) o peso do leitão ao nascer e número de leitões nascidos vivos e o peso dos leitões ao nascer. Já o uso de somatotropina aumenta o número de leitões desmamados (0,985; P<0,01). Não houve diferença significativa (P>0,05) entre as médias dos grupos dos tratamentos com L-carnitina, cromo, e somatotropina para o consumo de ração e condição corporal das porcas. O uso de ractopamina aumentou em 3,41 % (P<0,05) a espessura de toucinho ao parto. A suplementação com L-carnitina e cromo aumentaram em 2,30 % e 4,73 % (P<0,05) o número de leitões nascidos vivos, respectivamente. O uso da L-carnitina, arginina e somatotropina proporcionaram, em média, leitões mais pesados ao nascer em relação ao controle (1,48 vs. 1,43kg; P<0,05). A administração da somatotropina aumentou em 9,01 % (P<0,05) o número de leitões desmamados em relação ao controle. Os estudos sobre o uso de moduladores nutricionais encontrados na literatura são pouco explorados quanto a condição corporal e nutricional, o que impossibilita conclusões sobre o uso adequado destes aditivos para ajustes nutricionais em porcas gestantes e lactantes. Entretanto, os moduladores nutricionais L-carnitina, L-arginina, cromo e somatotropina podem melhorar o desempenho produtivo das porcas e de suas leitegadas. / The increase in productivity and nutritional demand by sows, the use of modulators L-carnitine, L-arginine, chromium, somatotropin and ractopamine has been an alternative to improve the productive indexes. However, the variability in information and the complexity of studies involving the subject requires a more systemic approach. The objective of this meta-analysis was to determine the effect of the use of nutritional modulators on the reproductive performance and litter of sows in gestation and lactation. The database used included 83 articles published between 1989 and 2017, totaling 22,608 sows in 534 treatments. Criteria were established for the selection of articles: use of nutritional modulators: L-carnitine, L-arginine, chromium, somatotropin and ractopamine; contain the body and reproductive variables of pregnant and lactating sows. The meta-analysis involved analyzes of heterogeneity, graph, correlation, variance and residuals. Don´t were significant correlations (P>0.05) between the body variables of the sows and nutritional modulators and their use. In correlation study, the L-carnitine, L-arginine and chromium supplementation increases (>0.450; P<0.05) the birth piglets weight and liveborn number. Somatotropin administration increased the weaner piglets number (0.985; P<0.01). There were no significant difference (P>0.05) between the means of groups with L-carnitine, chromium, and somatotropin for feed intake and body condition of the sows. Ractopamine use increased in 3.41% (P<0.05) the backfat thickness at farrowing. Supplementation with L-carnitine and chromium increased in 2.30 % e 4.73 % (P<0.05) the alive piglets number, respectively. The use of L-carnitine, L-arginine and somatotropin provided heavier piglets at birth in relation to control groups (1.48 vs. 1.43kg; P<0.05). Somatotropin administration increased in 9.01% (P<0.05) the of weaned piglets number in relation to control group. Studies on the use of nutritional modulators found in the literature are poorly explored in body and nutritional condition terms, which makes it impossible to reach conclusions about the proper use of these additives for nutritional adjustments in pregnant and lactating sows. However, the nutritional modulators L-carnitine, L-arginine, chromium and somatotropin can improve the productive performance of sows and their litters.

Ng Ho Yuen Andus. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (leaves 105-131). / Abstracts in English and Chinese. / Chapter I --- Title page --- p.i / Chapter II --- Thesis committee --- p.ii / Chapter III --- Acknowledgement --- p.iii / Chapter IV --- Abstract --- p.v / Chapter V --- Abstract (Chinese version) --- p.vii / Chapter V --- Table of contents --- p.ix / Chapter VI --- List of abbreviations --- p.xv / Chapter VII --- List of figures --- p.xviii / General introduction --- p.1 / Chapter Chapter 1: --- Literature review --- p.5 / Chapter 1.1. --- Heat shock proteins (HSPs) --- p.6 / Chapter 1.1.1. --- Introduction --- p.6 / Chapter 1.1.2. --- The various heat shock proteins --- p.8 / Chapter 1.1.2.1. --- HSP100s --- p.8 / Chapter 1.1.2.2. --- HSP90s --- p.9 / Chapter 1.1.2.3. --- HSP70s --- p.12 / Chapter 1.1.2.3.1. --- ATPase reaction cycle of HSP70 and protein folding --- p.13 / Chapter 1.1.2.3.2. --- Protein translocation --- p.14 / Chapter 1.1.2.3.3. --- Selective lysosomal proteolysis --- p.16 / Chapter 1.1.2.4. --- HSP60s --- p.16 / Chapter 1.1.2.5. --- Small HSPs --- p.17 / Chapter 1.1.2.6. --- Ubiquitin --- p.19 / Chapter 1.1.3. --- HSP studies in fish --- p.21 / Chapter 1.1.3.1. --- In vivo works --- p.21 / Chapter 1.1.3.2. --- In vitro works --- p.23 / Chapter 1.2. --- Growth hormone / prolactin family in teleostean fishes --- p.26 / Chapter 1.2.1. --- Introduction --- p.26 / Chapter 1.2.2. --- Growth hormone (GH; somatotropin) --- p.29 / Chapter 1.2.2.1. --- Structure --- p.29 / Chapter 1.2.2.2. --- Actions --- p.29 / Chapter 1.2.2.3. --- Insulin-like Growth Factors (IGFs; somatomedins) --- p.31 / Chapter 1.2.3. --- Prolactin (PRL) --- p.34 / Chapter 1.2.3.1. --- Structure --- p.34 / Chapter 1.2.3.2. --- Actions --- p.35 / Chapter 1.2.4. --- Somatolactin (SL) --- p.37 / Chapter 1.2.4.1. --- Structure --- p.37 / Chapter 1.2.4.2. --- Actions --- p.38 / Chapter 1.2.5. --- Growth hormone receptor (GH-R) and prolactin receptor (PRL-R) --- p.39 / Chapter 1.3. --- Cortisol in teleostean fishes --- p.41 / Chapter 1.4. --- Salinity adaptation in teleosts --- p.44 / Chapter Chapter 2: --- Effect of in vitro thermal shock on HSP70 expression in whole blood of Sparus sarba --- p.46 / Chapter 2.1. --- Introduction --- p.47 / Chapter 2.2. --- Materials and methods --- p.49 / Chapter 2.2.1. --- Overall experimental design --- p.49 / Chapter 2.2.2. --- Experimental fish --- p.49 / Chapter 2.2.3. --- Blood sampling and preparation --- p.49 / Chapter 2.2.4. --- Thermal stress regimes --- p.50 / Chapter 2.2.5. --- Protein extraction --- p.51 / Chapter 2.2.6. --- Protein quantification --- p.51 / Chapter 2.2.7. --- Indirect enzyme-linked immunosorbent assay (ELISA) --- p.52 / Chapter 2.2.8. --- Protein gel electrophoresis and immunoblotting (Western blotting) --- p.54 / Chapter 2.2.9. --- Statistical analysis --- p.55 / Chapter 2.3. --- Results --- p.56 / Chapter 2.3.1. --- Validation of indirect ELISA --- p.56 / Chapter 2.3.2. --- Effect of in vitro thermal shock on HSP70 expression in whole blood of Sparus sarba --- p.56 / Chapter 2.4. --- Discussion --- p.60 / Chapter 2.5. --- Conclusion --- p.64 / Chapter Chapter 3: --- Effects of hormones on HSP70 expression in whole blood of Sparus sarba in vitro --- p.65 / Chapter 3.1. --- Introduction --- p.66 / Chapter 3.2. --- Materials and methods --- p.68 / Chapter 3.2.1. --- Overall experimental design and experimental fish --- p.68 / Chapter 3.2.2. --- Hormone treatments --- p.59 / Chapter 3.2.3. --- "Protein extraction and quantification, indirect ELISA，gel electrophoresis, and immunoblotting (Western blotting)" --- p.70 / Chapter 3.2.4. --- Statistical analysis --- p.70 / Chapter 3.3. --- Results --- p.71 / Chapter 3.3.1. --- Effect of Cortisol on HSP70 levels in whole Blood --- p.71 / Chapter 3.3.2. --- Effect of recombinant bream growth hormone on HSP70 levels in whole blood --- p.71 / Chapter 3.3.3. --- Effect of recombinant bream insulin-like growth factor-I on HSP70 levels in whole blood --- p.71 / Chapter 3.3.4. --- Effect of ovine prolactin on HSP70 levels in whole blood --- p.72 / Chapter 3.4. --- Discussion --- p.81 / Chapter 3.4.1. --- Effect of Cortisol on HSP70 levels in whole Blood --- p.81 / Chapter 3.4.2. --- Effect of recombinant bream growth hormone on HSP70 levels in whole blood --- p.83 / Chapter 3.4.3. --- Effect of recombinant bream insulin-like growth factor-I on HSP70 levels in whole blood --- p.85 / Chapter 3.4.4. --- Effect of ovine prolactin on HSP70 levels in whole blood --- p.86 / Chapter 3.5. --- Conclusion --- p.88 / Chapter Chapter 4: --- Effect on HSP70 expression in whole blood of Sparus sarba acclimated to various salinities --- p.89 / Chapter 4.1. --- Introduction --- p.90 / Chapter 4.2. --- Materials and methods --- p.92 / Chapter 4.2.1. --- Overall experimental design and experimental fish --- p.92 / Chapter 4.2.2. --- "Protein extraction and quantification, indirect ELISA, gel electrophoresis, and immunoblotting (Western blotting)" --- p.92 / Chapter 4.2.3. --- Statistical analysis --- p.93 / Chapter 4.3. --- Results --- p.94 / Chapter 4.4. --- Discussion --- p.97 / Chapter 4.5. --- Conclusion --- p.100 / Chapter Chapter 5: --- General discussion and conclusion --- p.101 / References --- p.105

Made available in DSpace on 2015-03-26T13:47:09Z (GMT). No. of bitstreams: 1 texto completo.pdf: 269793 bytes, checksum: 7ace1f379fb4f111e4dbe56c3e1179e0 (MD5) Previous issue date: 2006-12-18 / Fundação de Amparo a Pesquisa do Estado de Minas Gerais / The objective of the present study was to evaluate the effect of the administration, of 500 mg rbST (recombinant bovine somatotropin) in the moment of estrous of recipient heifers and cows inovulation with fresh embryos and 250 and 500 mg rbST in recipient inovulated with defrosted embryos, in progesterone serum concentration (P4) on the day of the inovulation and at the pregnancy rate at day 30. Blood samples were collected in the day of the inovulation by puncture of the coccygeal vein or artery for assaying of the serum P4 concentration. 259 crossbred recipients, appraised as able for reproduction, were used and divided in two studies. In the first study 144 recipient heifers received fresh embryos, randomly sorted among the experiments. The control (T1) was composed by 77 recipients, and the treated (T2) 67 recipients that received 500mg rbST at the moment of estrous. In a second study, it was used 115 recipients that receive defrosted embryos subdivided in 3 treatments. 53 recipient heifers composed the control (T1), the treated 2 (T2) was composed by 22 recipients that received 250 mg of rbST and the treated 3 (T3) was composed by 40 recipients that received 500 mg of rbST. The pregnancy rate of the first study was 65.7% (44 pregnant recipients) among the animals of T2 and 32.5% (25 pregnant recipients) at T1, which demonstrates the positive effect (P<0.01) from the use of rbST on pregnancy rate. However, the average concentrations of serum P4 in the day of the inovulation was 2.54±0.19 mg/ml for the animals of T1 and 2.27±0.20 mg/ml for the T2, there was no difference (P>0.05). The pregnancy rate of the second study recipients was 45.3% (24 recipients) among the animals of the group T1, 50.0% (11 recipient) for T2 and 52.5% (21 recipient) for T3. The average concentrations of serum P4 in the day of the inovulation were: T1 (control) = 5.41±2.33 mg/ml, T2 (250 mg rbST) = 5.77±2.19 mg/ml and T3 (treated - 500 mg rbST) = 4.77 ± 1.78 mg/ml. The results of the second study demonstrate the absence of effect (P>0.05) on the rbST use over the pregnancy rate and the serum P4 concentration. We can conclude that the administration of 500 mg rbST in recipient inovulation that receive fresh embryo at the moment of the estrous was able to improve the pregnancy rate, but not the concentration of progesterone serum P4. However, when administered 250 or 500 mg rbST in recipient inovulated that receive defrosted embryos, we are able to conclude that there was no positive effect on the pregnancy rate and on the progesterone serum concentration. / O objetivo do presente estudo foi avaliar o efeito da administração, no dia do estro, de 500 mg de rbST (somatotropina bovina recombinante) em receptoras inovuladas com embriões transferidos à fresco e de 250 e 500 mg de rbST em receptoras inovuladas com embriões descongelados, sobre a concentração sérica de progesterona (P4) no dia da inovulação e a taxa de gestação aos 30 dias. As amostras de sangue foram coletadas no dia das inovulações por punção da veia ou artéria coccígea para análise da concentração sérica de P4. Foram utilizadas 259 receptoras mestiças, avaliadas como aptas a reprodução e divididas em dois estudos. No primeiro estudo foram utilizadas 144 receptoras, inovuladas com embriões à fresco, distribuídas aleatoriamente entre os tratamentos. O controle (T1) foi constituído por 77 receptoras e o tratado (T2) por 67 receptoras que receberam a administração de 500 mg de rbST no momento do estro. Em um segundo estudo utilizou-se 115 receptoras inovuladas com embriões descongelados subdivididas em três tratamentos. O controle (T1) foi constituido por 53 receptoras, o tratado 2 (T2) por 22 receptoras submetidas a administração de 250 mg de rbST e o tratado 3 (T3) por 40 receptoras que receberam a administração de 500 mg de rbST. As fêmeas do primeiro estudo apresentaram taxas de gestações de 65,7% (44 receptoras gestantes) entre os animais do grupo T2 e 32,5% (25 receptoras gestantes) para os do grupo T1, o que demonstra o efeito positivo (P<0,01) do uso da rbST sobre a taxa de gestação. Entretanto, as concentrações médias de P4 sérica no dia da inovulação foram de 2,54±0,19 ng/mL para os animais do T1 e 2,27±0,20 ng/mL para os do T2, não sendo observada diferença (P>0,05). No segundo estudo as taxas de gestações encontradas foram de 45,3% (24 receptoras) para T1, 50% (11 receptoras) para T2 e 52,5% (21 receptoras) para T3. As concentrações médias de P4 sérica no dia da inovulação foram de T1 (controle) = 5,41±2,33 ng/mL, T2 (250 mg rbST) = 5,77±2,19 ng/mL e T3 (500 mg rbST) = 4,77±1,78 ng/mL. Os resultados obtidos neste segundo estudo demonstram a ausência de efeito (P>0,05) do uso da rbST sobre as taxas de gestações e as concentrações séricas de P4. Concluiu-se que a aplicação de 500 mg de rbST em receptoras inovuladas com embriões à fresco no momento do estro, foi capaz de melhorar a taxa de gestação, mas não a concentração sérica de progesterona. No entanto, ao serem administradas 250 ou 500 mg de rbST receptoras inovuladas com embriões descongelados conclui-se a ausência de efeito positivo nas taxas de gestações e nas concentrações séricas de progesterona.